Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate

Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate

US Patent 8298537 · Granted Oct 30, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating early stage Dupuytren's disease2025
Methods for reducing post-operative cognitive dysfunction (POCD)2025
Method of treating dupuytren's disease using a pre-filled syringe2023
Method of treating a localized fibrotic disorder using an IL-33 antagonist2022
Methods for reducing post-operative cognitive dysfunction (POCD)2022
Method for treating rheumatoid arthritis with a human IL-6 receptor antibody and2020
Method of treating a localized fibrotic disorder using an IL-33 antagonist2019
Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and2013
Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and2013
Activation and inhibition of the immune system2011
Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and m2010
Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and m2010